{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:18:26Z","timestamp":1787242706895,"version":"build-2736575974"},"reference-count":96,"publisher":"Baskent University","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.6002\/ect.2019.0254","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T10:25:29Z","timestamp":1592389529000},"page":"659-670","source":"Crossref","is-referenced-by-count":20,"title":["Update on the Management of BK Virus Infection"],"prefix":"10.6002","volume":"18","author":[{"given":"Ahmed","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Salah","family":"El Din Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Takou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Halawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Imperiale MJ. The human polyomaviruses: an overview. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Wiley; 2001:53-71.","DOI":"10.1002\/0471221945.ch5"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Beimler J, Sommerer C, Zeier M. The influence of immunosuppression on the development of BK virus nephropathy-- does it matter? Nephrol Dial Transplant. 2007;22 Suppl 8:viii66-viii71. doi:10.1093\/ndt\/gfm646","DOI":"10.1093\/ndt\/gfm646"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Elfadawy N, Flechner SM, Schold JD, et al. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol. 2014;9(3):553-561. doi:10.2215\/CJN.08420813","DOI":"10.2215\/CJN.08420813"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(12):2058-2070. doi:10.2215\/CJN.04410512","DOI":"10.2215\/CJN.04410512"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol. 2008;3 Suppl 2:S68-75. doi:10.2215\/CJN.02770707","DOI":"10.2215\/CJN.02770707"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582-594. doi:10.1111\/j.1600-6143.2005.00742.x","DOI":"10.1111\/j.1600-6143.2005.00742.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation. 2012;94(8):814-821.doi:10.1097\/TP.0b013e31826690c6","DOI":"10.1097\/TP.0b013e31826690c6"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant. 2010;10(2):407-415. doi:10.1111\/j.1600-6143.2009.02952.x","DOI":"10.1111\/j.1600-6143.2009.02952.x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant. 2010;10(12):2615-2623. doi:10.1111\/j.1600-6143.2010.03310.x","DOI":"10.1111\/j.1600-6143.2010.03310.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Seifert ME, Gunasekaran M, Horwedel TA, et al. Polyomavirus reactivation and immune responses to kidney-specific self-antigens in transplantation. J Am Soc Nephrol. 2017;28(4):1314-1325. doi:10.1681\/ASN.2016030285","DOI":"10.1681\/ASN.2016030285"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Baksh FK, Finkelstein SD, Swalsky PA, Stoner GL, Ryschkewitsch CF, Randhawa P. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis. 2001;38(2):354-365. doi:10.1053\/ajkd.2001.26101","DOI":"10.1053\/ajkd.2001.26101"},{"key":"ref11","unstructured":"12. Garces JC. BK virus-associated nephropathy in kidney transplant recipients. Ochsner J. 2010;10(4):245-249."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology. 2013;437(2):63-72.doi:10.1016\/j.virol.2012.12.015","DOI":"10.1016\/j.virol.2012.12.015"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol. 1982;10(2):91-99. doi:10.1002\/jmv.1890100203","DOI":"10.1002\/jmv.1890100203"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol. 2009;47(8):2388-2391. doi:10.1128\/JCM.02472-08","DOI":"10.1128\/JCM.02472-08"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Boldorini R, Allegrini S, Miglio U, et al. Serological evidence of vertical transmission of JC and BK polyomaviruses in humans. J Gen Virol. 2011;92(Pt 5):1044-1050. doi:10.1099\/vir.0.028571-0","DOI":"10.1099\/vir.0.028571-0"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Boldorini R, Allegrini S, Miglio U, et al. BK virus sequences in specimens from aborted fetuses. J Med Virol. 2010;82(12):2127-2132. doi:10.1002\/jmv.21923","DOI":"10.1002\/jmv.21923"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Pahari A, Rees L. BK virus-associated renal problems--clinical implications. Pediatr Nephrol. 2003;18(8):743-748. doi:10.1007\/s00467-003-1184-3","DOI":"10.1007\/s00467-003-1184-3"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Peinemann F, de Villiers EM, Dorries K, Adams O, Vogeli TA, Burdach S. Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr. 2000;159(3):182-188. doi:10.1007\/s004310050047","DOI":"10.1007\/s004310050047"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant. 2005;5(8):1926-1933. doi:10.1111\/j.1600-6143.2005.00934.x","DOI":"10.1111\/j.1600-6143.2005.00934.x"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Howell DN, Smith SR, Butterly DW, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation. 1999;68(9):1279-1288. doi:10.1097\/00007890-199911150-00011","DOI":"10.1097\/00007890-199911150-00011"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis. 2006;193(1):80-87. doi:10.1086\/498530","DOI":"10.1086\/498530"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009;22(6):626-634. doi:10.1111\/j.1432-2277.2009.00842.x","DOI":"10.1111\/j.1432-2277.2009.00842.x"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Gralla J, Huskey J, Wiseman AC. Trends in immune function assay (ImmuKnow; Cylex) results in the first year post-transplant and relationship to BK virus infection. Nephrol Dial Transplant. 2012;27(6):2565-2570. doi:10.1093\/ndt\/gfr675","DOI":"10.1093\/ndt\/gfr675"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Fink JC, Wiland AM, Rochussen JR, Drachenberg CB, Papadimitriou JP. Increased incidence Of BK polyoma virus in renal transplant recipients treated with Prograf (Abstract 1051). Transplant J. 2000;69(8):S385.","DOI":"10.1097\/00007890-200004271-01051"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Dadhania D, Snopkowski C, Ding R, et al. Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation. 2008;86(4):521-528. doi:10.1097\/TP.0b013e31817c6447","DOI":"10.1097\/TP.0b013e31817c6447"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Lipshutz GS, Flechner SM, Govani MV, Vincenti F. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. Am J Transplant. 2004;4(12):2132-2134. doi:10.1046\/j.1600-6143.2004.00600.x","DOI":"10.1046\/j.1600-6143.2004.00600.x"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Sachdeva MS, Nada R, Jha V, Sakhuja V, Joshi K. The high incidence of BK polyoma virus infection among renal transplant recipients in India. Transplantation. 2004;77(3):429-431. doi:10.1097\/01.TP.0000113163.02039.30","DOI":"10.1097\/01.TP.0000113163.02039.30"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Hirsch HH, Yakhontova K, Lu M, Manzetti J. BK Polyomavirus replication in renal tubular epithelial cells is inhibited by sirolimus, but activated by tacrolimus through a pathway involving FKBP-12. Am J Transplant. 2016;16(3):821-832. doi:10.1111\/ajt.13541","DOI":"10.1111\/ajt.13541"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant. 2005;5(9):2213-2221. doi:10.1111\/j.1600-6143.2005.01000.x","DOI":"10.1111\/j.1600-6143.2005.01000.x"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Thomas A, Dropulic LK, Rahman MH, Geetha D. Ureteral stents: a novel risk factor for polyomavirus nephropathy. Transplantation. 2007;84(3):433-436. doi:10.1097\/01.tp.0000269616.21698.10","DOI":"10.1097\/01.tp.0000269616.21698.10"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Sharif A, Alachkar N, Bagnasco S, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(8):1320-1327. doi:10.2215\/CJN.00770112","DOI":"10.2215\/CJN.00770112"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Awadalla Y, Randhawa P, Ruppert K, Zeevi A, Duquesnoy RJ. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant. 2004;4(10):1691-1696. doi:10.1111\/j.1600-6143.2004.00563.x","DOI":"10.1111\/j.1600-6143.2004.00563.x"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol. 1980;74(3):326-332. doi:10.1093\/ajcp\/74.3.326","DOI":"10.1093\/ajcp\/74.3.326"},{"issue":"2","key":"ref34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trre.2007.03.001","article-title":"BK viral nephropathy: an overview","volume":"21","author":"Randhawa","year":"2007","unstructured":"35. Randhawa P, Ramos EJ. BK viral nephropathy: an overview. Transplant Rev. 2007;21(2):77-85.","journal-title":"Transplant Rev"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277-1286. doi:10.1097\/01.tp.0000156165.83160.09","DOI":"10.1097\/01.TP.0000156165.83160.09"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Wiseman AC. Polyomavirus nephropathy: a current perspective and clinical considerations. Am J Kidney Dis. 2009;54(1):131-142. doi:10.1053\/j.ajkd.2009.01.271","DOI":"10.1053\/j.ajkd.2009.01.271"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Drachenberg CB, Papadimitriou JC. Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis. 2006;8(2):68-75. doi:10.1111\/j.1399-3062.2006.00154.x","DOI":"10.1111\/j.1399-3062.2006.00154.x"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant. 2004;4(12):2082-2092. doi:10.1046\/j.1600-6143.2004.00603.x","DOI":"10.1046\/j.1600-6143.2004.00603.x"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant. 2000;15(3):324-332.doi:10.1093\/ndt\/15.3.324","DOI":"10.1093\/ndt\/15.3.324"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67(1):103-109. doi:10.1097\/00007890-199901150-00018","DOI":"10.1097\/00007890-199901150-00018"},{"key":"ref41","unstructured":"42. Traystman MD, Gupta PK, Shah KV, et al. Identification of viruses in the urine of renal transplant recipients by cytomorphology. Acta Cytol. 1980;24(6):501-510."},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13(8):2145-2151. doi:10.1097\/01.asn.0000023435.07320.81","DOI":"10.1097\/01.ASN.0000023435.07320.81"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488-496. doi:10.1056\/NEJMoa020439","DOI":"10.1056\/NEJMoa020439"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol. 1999;30(8):970-977. doi:10.1016\/s0046-8177(99)90252-6","DOI":"10.1016\/S0046-8177(99)90252-6"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46. Coleman DV, Gardner SD, Field AM. Human polyomavirus infection in renal allograft recipients. Br Med J. 1973;3(5876):371-375. doi:10.1136\/bmj.3.5876.371","DOI":"10.1136\/bmj.3.5876.371"},{"key":"ref46","unstructured":"47. Agha I, Alvarez A, Lopez L, Hardinger KL, Torrence S, Miller BJ. Human polyoma virus infects a high proportion of renal allograft recipients and the incidence is not affected by choice of calcineurin inhibitor. J Am Soc Nephrol. 2001;12:847A."},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48. Saundh BK, Baker R, Harris M, Welberry Smith MP, Cherukuri A, Hale A. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy. J Infect Dis. 2013;207(1):137-141. doi:10.1093\/infdis\/jis642","DOI":"10.1093\/infdis\/jis642"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49. Bardak S, Turgutalp K, Ball\u0131 E, et al. BK virus nephropathy in a renal transplant patient: Potential role of electron microscopy in diagnosis. Nefrologia. 2016;36(5):565-567. doi:10.1016\/j.nefro.2016.03.015","DOI":"10.1016\/j.nefro.2016.03.015"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med. 2000;342(18):1361-1363. doi:10.1056\/NEJM200005043421809","DOI":"10.1056\/NEJM200005043421809"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"51. Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol. 1984;37(5):578-586. doi:10.1136\/jcp.37.5.578","DOI":"10.1136\/jcp.37.5.578"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52. Shah KV. Human polyomavirus BKV and renal disease. Nephrol Dial Transplant. 2000;15(6):754-755. doi:10.1093\/ndt\/15.6.754","DOI":"10.1093\/ndt\/15.6.754"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53. Randhawa P, Bohl D, Brennan D, et al. Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol. 2008;15(10):1564-1571. doi:10.1128\/CVI.00206-08","DOI":"10.1128\/CVI.00206-08"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant. 2004;4(12):2109-2117. doi:10.1111\/j.1600-6143.2004.00629.x","DOI":"10.1111\/j.1600-6143.2004.00629.x"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation. 2003;75(8):1266-1270. doi:10.1097\/01.TP.0000061767.32870.72","DOI":"10.1097\/01.TP.0000061767.32870.72"},{"key":"ref55","unstructured":"56. Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol. 1989;36:42-61."},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009;20(2):416-427. doi:10.1681\/ASN.2008010117","DOI":"10.1681\/ASN.2008010117"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58. Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation. 2010;89(9):1057-1070. doi:10.1097\/TP.0b013e3181d0e15e","DOI":"10.1097\/TP.0b013e3181d0e15e"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"59. Weiss AS, Gralla J, Chan L, Klem P, Wiseman AC. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol. 2008;3(6):1812-1819. doi:10.2215\/CJN.05691207","DOI":"10.2215\/CJN.05691207"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60. Menter T, Mayr M, Schaub S, Mihatsch MJ, Hirsch HH, Hopfer H. Pathology of resolving polyomavirus-associated nephropathy. Am J Transplant. 2013;13(6):1474-1483. doi:10.1111\/ajt.12218","DOI":"10.1111\/ajt.12218"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"61. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant. 2005;5(8):1997-2004. doi:10.1111\/j.1600-6143.2005.00980.x","DOI":"10.1111\/j.1600-6143.2005.00980.x"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"62. Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant. 2007;39(12):783-787. doi:10.1038\/sj.bmt.1705678","DOI":"10.1038\/sj.bmt.1705678"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"63. Marty FM, Winston DJ, Rowley SD, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227-1236. doi:10.1056\/NEJMoa1303688","DOI":"10.1056\/NEJMoa1303688"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"64. Reisman L, Habib S, McClure GB, Latiolais LS, Vanchiere JA. Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child. Pediatr Transplant. 2014;18(7):E227-231.doi:10.1111\/petr.12340","DOI":"10.1111\/petr.12340"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"65. Papanicolaou GA, Lee YJ, Young JW, et al. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. Am J Kidney Dis. 2015;65(5):780-784. doi:10.1053\/j.ajkd.2014.11.020","DOI":"10.1053\/j.ajkd.2014.11.020"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"66. Liacini A, Seamone ME, Muruve DA, Tibbles LA. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation. 2010;90(12):1450-1457. doi:10.1097\/TP.0b013e3182007be2","DOI":"10.1097\/TP.0b013e3182007be2"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"67. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005;352(11):1157-1158. doi:10.1056\/NEJM200503173521125","DOI":"10.1056\/NEJM200503173521125"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"68. Krisl JC, Taber DJ, Pilch N, et al. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012;7(6):1003-1009. doi:10.2215\/CJN.12531211","DOI":"10.2215\/CJN.12531211"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"69. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006;81(5):704-710. doi:10.1097\/01.tp.0000181149.76113.50","DOI":"10.1097\/01.tp.0000181149.76113.50"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"70. Cuellar-Rodriguez J, Stephany B, Poggio E, et al. Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy. Clin Transplant. 2013;27(3):E230-236. doi:10.1111\/ctr.12110","DOI":"10.1111\/ctr.12110"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"71. Randhawa P, Pastrana DV, Zeng G, et al. Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK. Am J Transplant. 2015;15(4):1014-1020. doi:10.1111\/ajt.13083","DOI":"10.1111\/ajt.13083"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"72. Vu D, Shah T, Ansari J, Naraghi R, Min D. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients. Transplant Proc. 2015;47(2):394-398. doi:10.1016\/j.transproceed.2015.01.012","DOI":"10.1016\/j.transproceed.2015.01.012"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"73. Randhawa PS, Schonder K, Shapiro R, Farasati N, Huang Y. Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation. 2010;89(12):1462-1465. doi:10.1097\/tp.0b013e3181daaaf1","DOI":"10.1097\/TP.0b013e3181daaaf1"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"74. Gelfand EW. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2012;367(21):2015-2025. doi:10.1056\/NEJMra1009433","DOI":"10.1056\/NEJMra1009433"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"75. Sharma BN, Li R, Bernhoff E, Gutteberg TJ, Rinaldo CH. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res. 2011;92(1):115-123. doi:10.1016\/j.antiviral.2011.07.012","DOI":"10.1016\/j.antiviral.2011.07.012"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"76. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res. 1988;9(3):205-218. doi:10.1016\/0166-3542(88)90004-6","DOI":"10.1016\/0166-3542(88)90004-6"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"77. Wojciechowski D, Chanda R, Chandran S, et al. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012;94(11):1117-1123. doi:10.1097\/TP.0b013e31826ec74e","DOI":"10.1097\/TP.0b013e31826ec74e"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"78. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010;5(7):1298-1304. doi:10.2215\/CJN.08261109","DOI":"10.2215\/CJN.08261109"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79. Zaman RA, Ettenger RB, Cheam H, Malekzadeh MH, Tsai EW. A novel treatment regimen for BK viremia. Transplantation. 2014;97(11):1166-1171. doi:10.1097\/01.TP.0000441825.72639.4f","DOI":"10.1097\/01.TP.0000441825.72639.4f"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"80. Lee BT, Gabardi S, Grafals M, et al. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol. 2014;9(3):583-589. doi:10.2215\/CJN.04230413","DOI":"10.2215\/CJN.04230413"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"81. Knoll GA, Humar A, Fergusson D, et al. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA. 2014;312(20):2106-2114. doi:10.1001\/jama.2014.14721","DOI":"10.1001\/jama.2014.14721"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"82. Hirsch HH, Randhawa P, Practice ASTIDCo. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:179-188. doi:10.1111\/ajt.12110","DOI":"10.1111\/ajt.12110"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"83. Wright AJ, Gill JS. Strategies to prevent BK virus infection in kidney transplant recipients. Curr Opin Infect Dis. 2016;29(4):353-358. doi:10.1097\/QCO.0000000000000278","DOI":"10.1097\/QCO.0000000000000278"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"84. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992;257(5067):238-241. doi:10.1126\/science.1352912","DOI":"10.1126\/science.1352912"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"85. Icheva V, Kayser S, Wolff D, et al. Adoptive transfer of Epstein-Barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J Clin Oncol. 2013;31(1):39-48. doi:10.1200\/JCO.2011.39.8495","DOI":"10.1200\/JCO.2011.39.8495"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"86. Crough T, Beagley L, Smith C, Jones L, Walker DG, Khanna R. Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme. Immunol Cell Biol. 2012;90(9):872-880. doi:10.1038\/icb.2012.19","DOI":"10.1038\/icb.2012.19"},{"key":"ref86","unstructured":"87. Khanna R, Smith C. Cellular immune therapy for viral infections in transplant patients. Indian J Med Res. 2013;138(5):796-807."},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"88. Moosmann A, Bigalke I, Tischer J, et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood. 2010;115(14):2960-2970.doi:10.1182\/blood-2009-08-236356","DOI":"10.1182\/blood-2009-08-236356"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"89. Schmitt A, Tonn T, Busch DH, et al. Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion. 2011;51(3):591-599. doi:10.1111\/j.1537-2995.2010.02940.x","DOI":"10.1111\/j.1537-2995.2010.02940.x"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"90. Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood. 2010;116(20):4360-4367. doi:10.1182\/blood-2010-01-262089","DOI":"10.1182\/blood-2010-01-262089"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"91. Blyth E, Clancy L, Simms R, et al. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses. Transplantation. 2011;92(10):1077-1084. doi:10.1097\/TP.0b013e31823328c0","DOI":"10.1097\/TP.0b013e31823328c0"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"92. Papadopoulou A, Gerdemann U, Katari UL, et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014;6(242):242ra283. doi:10.1126\/scitranslmed.3008825","DOI":"10.1126\/scitranslmed.3008825"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"93. Nickeleit V, Mihatsch MJ. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int. 2006;19(12):960-973. doi:10.1111\/j.1432-2277.2006.00360.x","DOI":"10.1111\/j.1432-2277.2006.00360.x"},{"issue":"4","key":"ref93","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1034\/j.1600-6143.2001.10414.x","article-title":"Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology","volume":"1","author":"Drachenberg","year":"2001","unstructured":"94. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant. 2001;1(4):373-381.","journal-title":"Am J Transplant"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"95. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001;345(17):1250-1255. doi:10.1056\/NEJMoa010319","DOI":"10.1056\/NEJMoa010319"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"96. Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:179-88. doi:10.1111\/ajt.12110","DOI":"10.1111\/ajt.12110"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T01:48:48Z","timestamp":1605664128000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2020\/18\/6\/0\/659\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2019.0254","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}